Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid

This study is enrolling participants by invitation only.

Sponsor:

Information provided by (Responsible Party):

California Department of Public Health

ClinicalTrials.gov Identifier:

NCT01701999

First received: October 3, 2012

Last updated: February 5, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	December 2014
Estimated Primary Completion Date:	September 2014 (Final data collection date for primary outcome measure)